Home » Newsletters » BioWorld Science

BioWorld Science

March 20, 2002

View Archived Issues

Neotrofin protects against neurodegeneration in a rat model of Parkinson's disease

Once-weekly antidepressant safe and effective in natural clinical setting

Inhibition of UL70 primase as a promising approach to the treatment of cytomegalovirus infections

QYL-1064 and analogues effective against cytomegalovirus and certain other herpesviruses

UMJD-1369 identified as a potent, early-acting anti-HCMV pyrrolopyrimidine

Results reported in Barcelona for DNA and protein AutoVac HER-2 vaccines

Ezetimibe further improves lipoprotein profiles in statin-treated hypercholesterolemic patients

Compounds that prevent peptide metabolism reported by Sumitomo

Sankyo describes novel immunosuppressants in a recent patent

Steroid sulfatase inhibitors disclosed by Nippon Organon

Scientists at Aventis describe a new series of antidiabetic compounds

Melacure Therapeutics discloses melanocortin receptor ligands and their use

Novel LPS inhibitors synthesized at Mitsubishi Pharma

Ligand reports on 2001 highlights

Inex offers 2001 update

Swiss approval and launch of Tracleer announced

Amersham Health reports good progress in a number of areas during 2001

Zelnorm/Zelmac approved in Canada and Brazil

deCODE completes MediChem acquisition

Health Canada approves expanded label for ProstaScint

Boston Life Sciences initiates phase II study of Altropane for ADHD diagnosis

PowderJect to sell drug business to AlgoRx

PH-50 uptake in animal soft plaque tissue encouraging for early diagnosis of coronary artery disease

Encouraging results emerge from pilot phase III trial of Chronogesic

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...